© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Calcium levofolinate, also known as Calcium Folinate or folinic acid calcium salt, plays a big role in medical care, especially during chemotherapy. This material helps the body recover from the toxic effects of certain cancer drugs. Levofolinate stands out as the biologically active L-isomer of folinic acid, which supports DNA synthesis and cell repair. The compound is widely recognized under the HS Code 29349990 for customs and logistics purposes, reflecting its use as a pharmaceutical ingredient.
On the molecular level, calcium levofolinate has the formula C20H21CaN7O7 and carries a molecular weight of about 511.5 g/mol. The crystal structure forms a solid, usually appearing in pale yellow to white flakes, crystalline powder, or small pearls. The density usually reads close to 1.41 g/cm³ at room temperature, making it relatively easy to handle and mix in liquid solutions or pharmaceutical preparations. The material dissolves readily in water and creates a clear or slightly opalescent liquid when in solution form, often packaged in glass ampoules or vials to avoid contamination and light exposure. The stable solid form allows for long shelf-life if handled under dry, cool, and well-ventilated conditions.
Industries use calcium levofolinate both as a raw material and as a finished pharmaceutical ingredient for injectable, oral, or solution forms. For clinical applications, purity remains a critical factor, often kept at or above 98%. Any water present falls below 8%, and heavy metals remain strictly controlled under 10 ppm to keep patient risk low. As a powder, it clumps easily, so careful packing and storage become essential. In terms of volume, one liter of a standard solution contains approximately 100 mg of the active form, suited for direct infusion or dilution depending on treatment requirements.
Calcium levofolinate rates as relatively safe compared with many chemicals used in pharmaceuticals, but safety standards drive every step of handling and use. Accidental exposure can cause irritation of the eyes, skin, and respiratory system, and swallowing large amounts could bring on gastrointestinal distress. Strict labeling and hazard information must accompany every shipment, even for research or industrial batches, to avoid mishaps in laboratories or clinics. Workers often rely on gloves, goggles, and fume hoods to limit unnecessary contact. While it does not present explosive or highly flammable qualities, dust formed during transfer can cause a mess and present slips or respiratory risks in poorly ventilated spaces.
This folate derivative contains a pteridine ring system linked to para-aminobenzoic acid and glutamic acid groups, held together by ionic bonding with calcium. The structure enables it to function as a metabolic booster in folate metabolism, making it a vital cofactor in DNA replication and cellular division. Unlike folic acid, the active form doesn’t require reduction by dihydrofolate reductase, which benefits patients with specific enzyme deficiencies or those affected by antifolate drugs. Its chemical stability offers strong performance in a range of pharmaceutical formulations, from high-purity solid reagents to sterile injectable solutions.
Production starts with pure folinic acid, processed and neutralized with calcium carbonate or calcium chloride. Sourcing these precursors often relies on established chemical suppliers with experience meeting pharmaceutical grade benchmarks. Manufacturing follows strict good manufacturing practices, often audited to international standards, with thorough batch testing for contaminants, purity, and performance. The supply chain must balance quality control against cost, with some regions struggling with contamination, variable purity levels, or delays linked to regulatory bottlenecks that slow the flow of much-needed pharmaceutical raw materials. Consistent quality stands as the best defense against health risks, supply interruptions, or regulatory action.
Mislabeling, inconsistent purity, and contamination create the biggest headaches for buyers and manufacturers of calcium levofolinate. Stories of counterfeit or improperly stored batches point to the need for better traceability and strict lot tracking. To combat these issues, industries and regulators push for serialization, robust documentation, and increased random testing at points of entry. Digital monitoring and blockchain technology, though new in this area, offer strong tools for tracing materials from the factory floor to the hospital pharmacy. More support for staff training encourages safe handling, reduces accidental exposure, and keeps both workers and patients out of harm’s way. Global harmonization of standards reduces confusion and improves access for people who rely on life-saving therapies, where any shortfalls in quality can have big consequences.
Every patient getting a treatment that relies on folate metabolism stands to gain or lose from the quality of materials like calcium levofolinate. As the demand for personalized and cancer-related therapies continues to grow, the methods for manufacture, certification, and handling stay under pressure to keep up and respond quickly to emerging challenges in medicine, regulation, and logistics. Companies and clinicians together write the next chapter not only by driving progress but also by keeping safety, integrity, and science at the center of their work with these essential compounds.
